XML 44 R10.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Selected Balance Sheet Components | 12 Months Ended
--- | ---
Dec. 31, 2017
Selected Balance Sheet Components [Abstract] |
Selected Balance Sheet Components | 3. Selected Balance Sheet Components Accrued expenses and other current liabilities At December 31, 2017 and 2016, accrued expenses and other current liabilities were comprised of the following (in thousands):
|  | 2017 |  |  | 2016 |
Accrued bonuses and payroll related expenses |  | $ | 636 |  |  | $ | 549 |
Other accrued expenses |  |  | 406 |  |  |  | 248 |
Accrued expenses and other current liabilities |  | $ | 1,042 |  |  | $ | 797 |
Intangible assets, net In 2011, OncoCyte, through its then parent, BioTime, acquired substantially all of the assets of Cell Targeting, Inc., a company that was engaged in cancer therapy. The assets acquired consist primarily of patents, patent applications, and licenses to use certain patents. OncoCyte amortizes intangible assets over their useful lives estimated to be 10 years at the date of the acquisition. At December 31, 2017 and 2016, intangible assets were comprised of the following (in thousands):
|  | 2017 |  |  | 2016 |
Intangible assets |  | $ | 2,419 |  |  | $ | 2,419 |
Accumulated amortization |  |  | (1,673 | ) |  |  | (1,431 | )
Intangible assets, net |  | $ | 746 |  |  | $ | 988 |
Amortization expense amounted to approximately $242,000 annually. Equipment and furniture, net At December 31, 2017 and 2016, equipment and furniture were comprised of the following (in thousands):
|  | 2017 |  |  | 2016 |
Equipment and furniture |  | $ | 1,479 |  |  | $ | 1,007 |
Accumulated depreciation |  |  | (657 | ) |  |  | (319 | )
Equipment and furniture, net |  | $ | 822 |  |  | $ | 688 |
Depreciation expense amounted to approximately $338,000, $145,000 and $41,000 for the years ended December 31, 2017, 2016 and 2015, respectively. During the year ended December 31, 2017 and 2016, OncoCyte entered into capital leases for laboratory equipment totaling $381,000 and $626,000, respectively (see Note 9).

X
- References No definition available. + Details
Name: | ocx_SelectedBalanceSheetComponentsAbstract
Namespace Prefix: | ocx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -URI http://asc.fasb.org/topic&trid=2122208 + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration